Some early effects of cyclophosphamide therapy on Fortner plasmacytoma.
D000478:Alkylation; D000818:Animals; D002247:Carbon Isotopes; D002262:Carboxy-Lyases / Q000378:metabolism*; D006224:Cricetinae; D003520:Cyclophosphamide / Q000494:pharmacology* / Q000627:therapeutic use; D004254:DNA Nucleotidyltransferases; D004273:DNA, Neoplasm / Q000302:isolation & purification / Q000378:metabolism*; D003854:Deoxyribonucleotides; D004926:Escherichia coli / Q000201:enzymology; D007700:Kinetics; D008660:Metabolism / Q000187:drug effects; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism; D009952:Ornithine; D010954:Plasmacytoma / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism*; D013268:Stimulation, Chemical; D013997:Time Factors
D002247:Carbon Isotopes; D004273:DNA, Neoplasm; D003854:Deoxyribonucleotides; D003520:Cyclophosphamide; D009952:Ornithine; D004254:DNA Nucleotidyltransferases; D002262:Carboxy-Lyases